Genesis Capital is pleased to announce that Chroma Color Corporation (“Chroma”), a leading specialty color and additive concentrate supplier, has acquired Epolin Chemicals LLC (“Epolin”). Chroma is a portfolio company of Arsenal Capital Partners (“Arsenal”).
The acquisition of Epolin, with its global leadership in near-infrared absorbing dyes and thermoplastic compounds, significantly expands Chroma’s product offerings in targeted growth markets. Epolin serves customers developing groundbreaking products in sensors, security inks, light filters, touch-screens, night vision products, and eyewear. Epolin will operate as an independent subsidiary of Chroma Color and continue to maintain and invest in its strong customer and supplier relationships.
“This acquisition of Epolin will contribute significantly to Chroma Color’s leadership in the colorants and additives industry,” stated Tom Bolger, CEO of Chroma. “We are excited to add Epolin’s cutting-edge NIR Dye technology to our expanding product portfolio and the members of the Epolin team to the Chroma family.”
Matt Barr, Vice Chairman, Chroma Color, added; “There is also a tremendous opportunity for cross-selling by our team when IR absorption is part of an application combined with traditional color.”
“Of the many advantages Epolin customers will enjoy as a result of this transaction is access to Chroma Color’s extensive product development, testing, and validation capabilities. Epolin’s customers can now be served by Chroma Color’s ongoing R&D efforts to deliver new solutions for the markets that both Epolin and Chroma Color serve,” stated Greg Amato, CEO, Epolin.
Genesis Capital LLC acted as the investment banking advisor to Chroma Color, and Grace Matthews provided advisory services to Arsenal Capital Partners. The law firm of Benesch, Friedlander, Coplan & Aronoff LLP acted a legal counsel to Chroma Color. BDA Partners acted as the investment banking advisor to Epolin.
About Chroma Color Corporation
Chroma Color Corporation is a leading specialty color and additive concentrate supplier serving a diverse range of markets, including packaging, healthcare, pharmaceutical, consumer products and others. Chroma Color’s growth strategy includes both robust organic and inorganic growth and has been built through six acquisitions over more than two years. Chroma’s extensive technical leadership and manufacturing expertise, coupled with its game-changing colorant and light management technologies, have delighted customers for over 50 years.
About Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, completed more than 45 platform investments and achieved more than 30 realizations. Arsenal invests in industry sectors in which the firm has significant prior knowledge and experience. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.